2017
Inhalation of Alcohol Vapor: Measurement and Implications
MacLean RR, Valentine GW, Jatlow PI, Sofuoglu M. Inhalation of Alcohol Vapor: Measurement and Implications. Alcohol Clinical And Experimental Research 2017, 41: 238-250. PMID: 28054395, PMCID: PMC6143144, DOI: 10.1111/acer.13291.Peer-Reviewed Original ResearchConceptsAlcohol inhalationAlcohol consumptionAcute alcohol exposureElevated blood alcohol concentrationsRoute of administrationOral alcohol consumptionFirst-pass metabolismAlcohol use disorderPublic health concernMeasurement of biomarkersBlood alcohol concentrationRisk of addictionPharmacodynamic profileAlcohol exposureArterial circulationOccupational exposureMeasurable biomarkersPharmacological effectsUse disordersInhalationE-cigarettesHealth concernSubjective effectsRisk of problemsGoogle Scholar
2012
Oral Chemotherapeutic Agents
Ogita S, LoRusso P, Li J. Oral Chemotherapeutic Agents. 2012, 1-37. DOI: 10.1002/9780470921920.edm132.Peer-Reviewed Original ResearchOral chemotherapeutic agentsInterindividual pharmacokinetic variabilityChemotherapeutic agentsPharmacokinetic variabilityImmune-modulating agentsTraditional cytotoxic agentsFirst-pass metabolismClass of agentsCytochrome P450 3A4Mechanism of actionAntiacid medicationOral agentsConcomitant administrationIntestinal effluxHormonal agentsIntravenous agentsFood effectDrug dispositionABCB1 transporterDrug resistanceClinical useCytotoxic agentsStaff time savingsP450 3A4Noninvasive administration
2002
The Evolving Role of Estrogen Therapy in Prostate Cancer
Oh W. The Evolving Role of Estrogen Therapy in Prostate Cancer. Clinical Genitourinary Cancer 2002, 1: 81-89. PMID: 15046698, DOI: 10.3816/cgc.2002.n.009.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, OralAgedAndrogen AntagonistsDiethylstilbestrolDose-Response Relationship, DrugDrug Administration ScheduleDrug Resistance, NeoplasmEstrogensFollow-Up StudiesHumansMaleMiddle AgedNeoplasm StagingProstate-Specific AntigenProstatic NeoplasmsRandomized Controlled Trials as TopicRisk AssessmentTreatment OutcomeConceptsLuteinizing hormone-releasing hormoneEstrogen therapyProstate cancerAndrogen-independent prostate cancer patientsHepatic first-pass metabolismNormal prostate developmentOral estrogen therapyToxicity of diethylstilbestrolNormal prostate epitheliumParenteral route of administrationMetastatic prostate cancerPhase II trialProstate-specific antigenProstate cancer patientsSafety of EstrogensRisk of thromboembolismHormone-releasing hormoneFirst-pass metabolismPrimary medical treatmentActivity of diethylstilbestrolRoute of administrationProstate developmentProstate epitheliumDevelopment of cancerLHRH agonist
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply